These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3375045)
1. [WHO and drugs]. Westerholm B Nord Med; 1988; 103(5):158-60. PubMed ID: 3375045 [No Abstract] [Full Text] [Related]
2. Drugs for the elderly. Second edition. World Health Organization. Offerhaus L WHO Reg Publ Eur Ser; 1997; 71():1-145. PubMed ID: 9103908 [No Abstract] [Full Text] [Related]
3. [Voluntary reporting of adverse reactions to drugs]. Laporte JR; Porta M; Capellà D; Frati ME Med Clin (Barc); 1982 Oct; 79(6):287-91. PubMed ID: 6755090 [No Abstract] [Full Text] [Related]
4. The use of essential drugs. Report of a WHO expert committee. World Health Organ Tech Rep Ser; 1983; 685():1-46. PubMed ID: 6408810 [No Abstract] [Full Text] [Related]
5. Principles for the clinical evaluation of drugs. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser; 1968; 403():1-32. PubMed ID: 4972959 [No Abstract] [Full Text] [Related]
6. World Health Organization program for the selection and use of essential medicines. Reidenberg MM Clin Pharmacol Ther; 2007 Apr; 81(4):603-6. PubMed ID: 17314928 [TBL] [Abstract][Full Text] [Related]
7. Adverse reactions to drugs. WHO research centre. Venulet J Int J Clin Pharmacol; 1973 Apr; 7(2):253-64. PubMed ID: 4731291 [No Abstract] [Full Text] [Related]
8. [Information of the World health organization on adverse effects and contraindications of various drugs]. Navrátil K; Buriánek J Cas Lek Cesk; 1970 Jan; 109(4):94-5. PubMed ID: 5412528 [No Abstract] [Full Text] [Related]
9. International aspects of drug monitoring. Role of the World Health Organization. Royall BW WHO Chron; 1971 Oct; 25(10):445-51. PubMed ID: 5131672 [No Abstract] [Full Text] [Related]
10. [Drug problems in the WHO]. Lindgren SA Lakartidningen; 1966 Jul; 63(28):2641-4. PubMed ID: 5953348 [No Abstract] [Full Text] [Related]
12. International aspects of the study of adverse reactions to drugs. Royall BW Biometrics; 1971 Sep; 27(3):689-98. PubMed ID: 4940381 [No Abstract] [Full Text] [Related]
13. [The WHO program of action for essential medicinal drugs and vaccines. Rational use of drugs]. Soins Pathol Trop; 1984; (50):16. PubMed ID: 6570594 [No Abstract] [Full Text] [Related]
14. International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser; 1972; 498():1-25. PubMed ID: 4625548 [No Abstract] [Full Text] [Related]
15. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708 [No Abstract] [Full Text] [Related]
16. [International cooperation in assembling adverse drug effects. A scientific trial program as a pilot study of the World Health Organization]. Homann G Zahnarztl Mitt; 1968 Jul; 58(13):635-6. PubMed ID: 5243097 [No Abstract] [Full Text] [Related]
17. The use of essential drugs. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser; 1985; 722():5-50. PubMed ID: 3936282 [No Abstract] [Full Text] [Related]
18. WHO Expert Committee on drug dependence. World Health Organ Tech Rep Ser; 1993; 836():1-44. PubMed ID: 8273375 [No Abstract] [Full Text] [Related]
19. [1st practical results of international drug surveillance]. Lopes HV Rev Paul Med; 1972 Jul; 80(1):59-62. PubMed ID: 4671573 [No Abstract] [Full Text] [Related]
20. World Health Organization, European symposium on the toxicology of drugs, Moscow, 24-28 February 1964. Concepts for the promotion of safety in the use of drugs in man. Koll W Pharmakotherapia; 1964; 2(1):231-8. PubMed ID: 5875720 [No Abstract] [Full Text] [Related] [Next] [New Search]